InspectIR Nabs First FDA Approval for a SARS-CoV-2 Breathalyzer
On April 14, the FDA announced that, for the first time, it has granted Emergency Use Authorization for a COVID-19 breathalyzer test.
Subscribe to Clinical Diagnostics Insider to view
Start a Free Trial for immediate access to this article